<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://usa.alphagenics.co/blog/glp-1-ra-agonistas-receptor-glp1-que-son/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>GLP-1 RA: What GLP-1 Receptor Agonists Are</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/rare-glp1r-variants-semaglutide-tirzepatide-helix-ashg-2026/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>Rare GLP1R Variants Blunt Semaglutide, Not Tirzepatide: ASHG Data</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/acne-rosacea-tratamiento-peptidos-evidencia/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Acne and rosacea: treatment and what peptide research shows</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/ansiedad-tratamiento-y-que-muestran-selank-oxitocina/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Anxiety: treatment and what peptide research shows</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/apnea-del-sueno-que-es-tratamiento-y-tirzepatida/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Sleep apnea: what it is, treatment and tirzepatide</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/artrosis-de-rodilla-tratamiento-glp1-bpc-157/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Knee osteoarthritis: treatment, GLP-1s and BPC-157</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/cancer-de-prostata-avanzado-tratamiento-gnrh/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Advanced Prostate Cancer: Treatment and GnRH Evidence</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/caquexia-cancer-anamorelina-grelina-evidencia/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Cancer cachexia: treatment and what anamorelin evidence shows</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/depresion-que-es-tratamiento-y-peptidos-evidencia/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Depression: treatment and what peptide research shows</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/disfuncion-erectil-tratamiento-evidencia-peptidos/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Erectile dysfunction: treatment and peptide evidence</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/fda-glp1-naion-neuropatia-optica-etiqueta-2026/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>FDA Orders NAION Warning on All GLP-1 Drugs: What the Data Show</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/first-sale-hhs-peptide-enforcement-discretion-corexa-datameds/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>First Sale Under HHS Peptide Enforcement Discretion: What It Means</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/hepatitis-b-cronica-tratamiento-timosina-alfa-1/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Chronic hepatitis B: treatment and what thymosin alpha-1 shows</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/hims-hers-lilly-zepbound-foundayo-end-mass-compounding/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Hims &amp; Hers Sells Zepbound and Foundayo, Moving Away From Compounded GLP-1s</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/hipertension-arterial-pulmonar-tratamiento-sotatercept/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Pulmonary arterial hypertension: treatment and sotatercept</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/hipogonadismo-masculino-tratamiento-hcg-kisspeptina/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Male hypogonadism: treatment and what hCG and kisspeptin show</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/infertilidad-estimulacion-ovarica-gnrh-kisspeptina/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Infertility: treatment and what GnRH peptide research shows</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/insuficiencia-cardiaca-fevi-preservada-glp1/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>HFpEF: what the GLP-1 trials show (semaglutide, tirzepatide)</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/medicamentos-glp1-comparacion-agonistas-aprobados/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>GLP-1 medications compared: every approved drug</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/migrana-que-es-tratamiento-y-bloqueadores-de-cgrp/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Migraine: treatment and what CGRP blockers show</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/narcolepsia-tratamiento-y-que-muestra-la-orexina/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Narcolepsy: treatment and what orexin research shows</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/osteoporosis-tratamiento-teriparatida-abaloparatida/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Osteoporosis: treatment and teriparatide evidence</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/oxitocina-parto-posparto-hemorragia-carbetocina/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Oxytocin in labor and postpartum: uses, risks, evidence</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/parkinson-tratamiento-glp1-exenatida-lixisenatida/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Parkinson&#x27;s disease: treatment and what GLP-1 trials show</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/psoriasis-que-es-tratamiento-y-icotrokinra/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Psoriasis: treatment and what icotrokinra shows</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/sarcopenia-que-es-tratamiento-y-peptidos-glp1/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Sarcopenia: what it is, treatment and what peptides show</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/sindrome-ovario-poliquistico-tratamiento-glp1/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Polycystic ovary syndrome: treatment and what GLP-1s show</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/survodutide-cardiovascular-safety-synchronize-cvot/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>Survodutide: No CV Safety Signal, but 1 in 5 Stopped Treatment</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/vih-tratamiento-tesamorelina-enfuvirtida-timosina/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-09</news:publication_date><news:title>HIV: treatment and what peptide research has shown</news:title></news:news></url></urlset>
